Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0002034665-25-000011

President and COO sold 12,500 shares at $18.68 ($233,548)

  • President and COO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohlhepp Ryan President and COO 2025-12-15 Option exercise 10b5-1 +8,000 $3.79 $30,318 201,641 D: show line 1 in the form
Cohlhepp Ryan President and COO 2025-12-15 Sale 10b5-1 −8,000 $18.68 $149,470 193,641 D: show line 2 in the form
Cohlhepp Ryan President and COO 2025-12-15 Sale 10b5-1 −4,500 $18.68 $84,077 189,141 D: show line 3 in the form
Open-market sales · 12,500 sh · avg $18.68 · $233,548

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohlhepp Ryan President and COO 2025-12-15 Option exercise · Stock Option (Right to Buy) 10b5-1 −8,000 141,334 D: show line 4 in the form
Loading xslF345X05/wk-form4_1765921919.xml…